To determine the clinical relevance of IGF2BP3 in MCC, we first analyzed IGF2BP3 mRNA levels in the GSE235092 cohort, which comprised tumors classified as stage I–II, III, or IV. The gene discussed is IGF2BP3; the disease is Merkel cell skin cancer.